Co-founder, Chief Executive Officer

>25 years industry leadership experience

Founded OrphoMed, Inc., closing $43 million Series A financing

Over 100 patents

Invented and oversaw the development and approval of Intermezzo®

Developed patented formulations with unique therapeutic positioning for Vicks® Formula 44® and Nyquil®

Co-Founder, Chief Financial Officer

>25 years industry leadership experience

CFO at OrphoMed, Inc., closing $43 million Series A financing and $3M in debt financing

Senior financial roles at Adamas Pharma, Novacea, Inc., and 3Com Corp.

Founded Beyer Financial Consulting in 2009 to serve clients in the biotechnology and technology industries

Chief Medical Officer, Consultant

>30 years industry leadership experience

Led clinical activities for 7 US NDAs and 5 EU Market authorizations (including Durogesic® D-trans Patch & Electrotransport fentanyl patch; IONSYS®)

Led or co-led over $400M in private & public financings (including Satsuma IPO)

Led building of multiple companies (Ilypsa; Sorbent; Satsuma)